Antecedents of Obesity Among Children Born Extremely Preterm

Charles T Wood1, Olivia Linthavong2, Eliana M Perrin3

  • 1Division of Primary Care Pediatrics, Department of Pediatrics, Duke Center for Childhood Obesity Research, School of Medicine, Duke University, Durham, North Carolina; charles.wood@duke.edu.

Pediatrics
|October 7, 2018
PubMed

Insights

Maternal prepregnancy BMI and rapid infant weight gain increase childhood obesity risk. Risk factors for obesity in preterm infants at age 10 are similar to those in full-term infants.

Area of Science:

  • Pediatrics
  • Public Health
  • Neonatology

Background:

  • Childhood obesity is a significant public health concern.
  • Maternal prepregnancy BMI and rapid infant weight gain are known risk factors.
  • The association between early life growth and later obesity in preterm infants is unclear.

Purpose of the Study:

  • To investigate the relationship between early life factors and the risk of overweight and obesity at 10 years of age in children born extremely preterm.
  • To compare these risk profiles with those of children born at term.

Main Methods:

  • Prospective observational study using data from the Extremely Low Gestational Age Newborn Study.
  • Follow-up at 10 years of age for BMI assessment.
  • Multivariable regression analysis to identify risk factors for overweight and obesity.

Main Results:

  • High maternal prepregnancy BMI (≥25) and top quartile infant weight gain in the first year were associated with increased risk of overweight and obesity at 10 years.
  • Single marital status and exposure to tobacco smoke were also identified as risk factors.

Conclusions:

  • Risk profiles for overweight and obesity at 10 years of age in extremely preterm infants are similar to those in term-born infants.
  • Early life factors like maternal BMI and infant growth play a crucial role in later obesity risk.
Abstract

Related Concept Videos

The Born-Haber Cycle02:44

The Born-Haber Cycle

Lattice Energy 
25.4K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Absolute and Local Extreme Values01:22

Absolute and Local Extreme Values

The highest and lowest values of a function, relative to a reference axis, are known as extreme values. These include absolute maximum and absolute minimum values, which represent the highest and lowest points the function reaches across its entire domain. Within a restricted portion of the function, the highest and lowest values are referred to as local maximum and local minimum values, respectively.Periodic functions, such as sine and cosine, show extreme values at infinitely many points due...
74
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
282